NKG2D/CD314 Antibody (149810) [Alexa Fluor® 700]

This product is provided under an agreement between Life Technologies Corporation and R&D Systems, Inc, and the manufacture, use, sale or import of this product is subject to one or more US patents and corresponding non-US equivalents, owned by Life Technologies Corporation and its affiliates. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The sale of this product is expressly conditioned on the buyer not using the product or its components (1) in manufacturing; (2) to provide a service, information, or data to an unaffiliated third party for payment; (3) for therapeutic, diagnostic or prophylactic purposes; (4) to resell, sell, or otherwise transfer this product or its components to any third party, or for any other commercial purpose. Life Technologies Corporation will not assert a claim against the buyer of the infringement of the above patents based on the manufacture, use or sale of a commercial product developed in research by the buyer in which this product or its components was employed, provided that neither this product nor any of its components was used in the manufacture of such product. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, Cell Analysis Business Unit, Business Development, 29851 Willow Creek Road, Eugene, OR 97402, Tel: (541) 465-8300. Fax: (541) 335-0354.

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 1 confirmed species: Human.

We have publications tested in 2 applications: Flow Cytometry, ICC.

Showing Publications 1 - 5 of 5.

Publications using FAB139N	Applications	Species
Jürgens, M;Claus, M;Wingert, S;Niemann, JA;Picard, LK;Hennes, E;Haasler, I;Hellwig, B;Overbeck, N;Reinders, J;Rahnenführer, J;Schedel, M;Capellino, S;Watzl, C; Chronic stimulation desensitizes ?2-adrenergic receptor responses in natural killer cells European journal of immunology 2024-09-30 [PMID: 39350450] (Flow Cytometry, Human)	Flow Cytometry	Human
Picard, LK;Niemann, JA;Littwitz-Salomon, E;Waldmann, H;Watzl, C; Restriction of Glycolysis Increases Serial Killing Capacity of Natural Killer Cells International journal of molecular sciences 2024-03-02 [PMID: 38474166] (Flow Cytometry, Human)	Flow Cytometry	Human
LK Picard, E Littwitz-S, H Waldmann, C Watzl Inhibition of Glucose Uptake Blocks Proliferation but Not Cytotoxic Activity of NK Cells Cells, 2022-11-03;11(21):. 2022-11-03 [PMID: 36359883] (Flow Cytometry, Human)	Flow Cytometry	Human
van Meijgaarden K, Haks M, Caccamo N, Dieli F, Ottenhoff T, Joosten S Human CD8+ T-cells recognizing peptides from Mycobacterium tuberculosis (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human T-cell subset. PLoS Pathog, 2015-03-24;11(3):e1004671. 2015-03-24 [PMID: 25803478] (Flow Cytometry, Human)	Flow Cytometry	Human
Martin-Antonio B, Najjar A, Robinson S, Chew C, Li S, Yvon E, Thomas M, Mc Niece I, Orlowski R, Munoz-Pinedo C, Bueno C, Menendez P, Fernandez de Larrea C, Urbano-Ispizua A, Shpall E, Shah N Transmissible cytotoxicity of multiple myeloma cells by cord blood-derived NK cells is mediated by vesicle trafficking. Cell Death Differ, 2014-08-29;22(1):96-107. 2014-08-29 [PMID: 25168239] (ICC, Human)	ICC	Human

Array FAB139N

• NKG2D/CD314 Antibodies
• NKG2D/CD314 Protein
• NKG2D/CD314 Proteins and Enzymes